Combivent Inhaler Provides Reinforcement to Regular Treatment of COPD
Combivent Inhaler Provides Reinforcement to Regular Treatment of COPD
Combivent Inhaler Provides Reinforcement to Regular Treatment of COPD
Combivent Inhaler is a bronchodilator aerosol in the form of an oral inhaler, with the active ingredients ipratropium bromide and albuterol sulphate in metered form. Combivent Inhaler is manufactured by Boehringer Ingelheim and contains a microcrystalline suspension of ipratropium bromide and albuterol sulfate in a pressurized metered-dose aerosol unit for oral inhalation administration.
Combivent Inhaler Indications
This Inhaler is used for treating patients with chronic obstructive pulmonary disease (COPD) already using a regular inhaler but who continue to exhibit symptoms of bronchospasm and need an additional bronchodilator boost. Physicians recommend two inhalations four times a day. In fact, it is recommended that the daily number of inhalations should not exceed 12. Each actuation meters 21 mcg of ipratropium bromide and 120 mcg of albuterol sulfate from the valve and delivers 18 mcg of ipratropium bromide and 103 mcg of albuterol sulfate (equivalent to 90 mcg albuterol base) from the mouthpiece.
The Combivent Inhaler comes in the form of a white mouthpiece that has a clear, colourless sleeve and an orange protective cap. The manufacturer recommends that the Combivent Inhaler be used with the Inhalation Aerosol mouthpiece alone. Each canister provides sufficient medication for 200 actuations.
Combivent Inhaler Side Effects
Although certain complications and side effects have been reported with the prolonged use of Combivent Inhaler, by and large it is a rare occurrence if the physician's dose is adhered to. Combivent Inhaler can affect some cardiac functions in the body such as palpitations and angina. Some of the common allergic reactions to the medication are:
Rash
Urticaria
Oropharyngeal edema
Angioedema (swelling beneath the skin)
Bronchospasm
Dry mouth
Vomiting
Diarrhea
Nausea
Weakness
Tremor
Joint pain
Dizziness
Insomnia
Urinary tract infection
Combivent Contra Indications
Combivent Inhaler is contra indicated in individuals with an allergy to soybeans and peanuts. Spraying in eyes should be avoided.
Using Combivent Inhaler
Shake the canister vigorously before use
Never use near an open flame
The mouthpiece of the canister will have an orange protective cap. Remove it from the mouthpiece before use
If using for the first time or after more than 24 hours, spray it three times into the air before use
Keep eyes closed while inhaling the medication
Inhale the medication very slowly through the mouth
After inhaling the medication, try to hold your breath
Take away the mouthpiece from the mouth and try to exhale slowly
The second dose has to be taken ten minutes after the first inhalation
Wash and clean the mouthpiece with soap and water. Dry the mouthpiece and keep it capped.
Combivent Inhaler Storage
It is recommended to store it at 25 degree centigrade or at room temperature, taking care to keep away from moisture. The canister should be shaken for at least 10 seconds before use. Exposure to high temperatures might cause it to puncture. Precautions should be taken to keep away from children and refrain from puncturing the canister.
http://www.articlesbase.com/medicine-articles/combivent-inhaler-provides-reinforcement-to-regular-treatment-of-copd-4452550.html
Biomarkers help provide breakthrough in prostate cancer research Perfect Sedation Treatment On Time The Perfect Gift: A Couples Massage Treatment Does wood lamp in reality aid in the vitiligo treatment?? Effective Anorexia Remedies - Loss of Appetite Treatment Effective Constipation Treatment - Permanent Natural Cure Effective Treatment for Loss of Appetite - Anorexia Remedies Are all Vitiligo Treatments Fake? Sun Protection Cream – A Conventional Treatment For Vitiligo Does Hyperthyroidism Treatment Can Cure Vitiligo Successful Toe Fungus Treatment Is Very Difficult Acid Reflux Treatment Methods Treatments for baldness
Combivent Inhaler Provides Reinforcement to Regular Treatment of COPD Mountain View